
The Debut of Inflammatory Musculoskeletal Pathology in Patients Receiving Anticancer Therapy with PD-1/PD-L1 Pathway Inhibitors
Author(s) -
Anastasia Koltakova,
А. М. Лила,
О. Г. Алексеева,
А. А. Феденко,
Y. V. Gridneva,
A. S. Olshanskaya
Publication year - 2022
Publication title -
sovremennaâ revmatologiâ
Language(s) - English
Resource type - Journals
eISSN - 2310-158X
pISSN - 1996-7012
DOI - 10.14412/1996-7012-2022-5-46-52
Subject(s) - medicine , pembrolizumab , nivolumab , rash , cancer , melanoma , gastroenterology , immunotherapy , cancer research